{
    "root": "312bbb25-c5d0-ff31-e063-6394a90afc48",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Nystatin",
    "value": "20250325",
    "ingredients": [
        {
            "name": "EDETATE CALCIUM DISODIUM",
            "code": "25IH6R4SGF"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH"
        },
        {
            "name": "BENTONITE",
            "code": "A3N5ZCN45C"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "NYSTATIN",
            "code": "BDF1O1C72E"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        }
    ],
    "indications": "nystatin oral suspension indicated treatment infections oral cavity caused candida albicans .",
    "contraindications": "infants : 2 ml ( 200,000 units ) four times daily ( 1 ml side mouth ) . pediatric patients adults : 4 6 ml ( 400,000 600,000 units ) four times daily ( one-half dose side mouth ) . note : limited neonates , including premature low-birth weight neonates , indicate 1 ml ( 100,000 units ) four times daily effective . local treatment continued least 48 hours perioral symptoms disappeared and/or cultures returned normal . recommended retained mouth long possible swallowing .",
    "warningsAndPrecautions": "nystatin oral suspension , usp bright yellow color suspension cherry flavor containing 100,000 units nystatin per ml , supplied follows : ndc 62135-813-46 – bottle 60 ml ndc 62135-813-47 – bottle 473 ml ndc 62135-813-05 – 5 ml unit dose cups ndc 62135-813-24 – 20 unit dose cups 5 ml store controlled room temperature 20°c 25°c ( 68°f -77°f ) . freeze manufactured : chartwell rx , llc . congers , ny 10920 l71884 rev . 10/2024",
    "adverseReactions": "nystatin contraindicated patients history hypersensitivity nystatin suspension components .",
    "indications_original": "Nystatin oral suspension is indicated for the treatment of infections of the oral cavity caused by\n \n  Candida albicans.",
    "contraindications_original": "Infants: 2 mL (200,000 units) four times daily (1 mL in each side of mouth).\n                  Pediatric patients and adults: 4 to 6 mL (400,000 to 600,000 units) four times daily (one-half of dose in each side of mouth).\n                  NOTE: Limited clinical studies in neonates, including premature and low-birth weight neonates, indicate that 1 mL (100,000 units) four times daily is effective. \n                  Local treatment should be continued at least 48 hours after perioral symptoms have disappeared and/or cultures returned to normal. It is recommended that the drug be retained in the mouth as long as possible before swallowing.",
    "warningsAndPrecautions_original": "Nystatin Oral Suspension, USP is a bright yellow color suspension with cherry flavor containing 100,000 units of nystatin per mL, supplied as follows:\n                  NDC 62135-813-46 – bottle of 60 mL\n                  NDC 62135-813-47 – bottle of 473 mL\n                  NDC 62135-813-05 – 5 mL Unit Dose Cups\n                  NDC 62135-813-24 – 20 Unit Dose Cups of 5 mL each\n                  \n                  Store at controlled room temperature between 20°C to 25°C (68°F -77°F).\n                  \n                     DO NOT FREEZE\n                  \n                  \n                  \n                     Manufactured for:\n                       Chartwell RX, LLC. \n    Congers, NY 10920\n\n \n                  \n                  L71884\n                  Rev. 10/2024",
    "adverseReactions_original": "Nystatin is contraindicated in patients with a history of hypersensitivity to nystatin or any of the suspension components."
}